image
Mobile_image
eyebrow
For adults with classical Hodgkin lymphoma after a stem cell transplant
headline

Keep your momentum

content
ADCETRIS is approved to treat adults with classical Hodgkin lymphoma at high risk of coming back or becoming worse after a stem cell transplant.

Learn how people with classical Hodgkin lymphoma who had a stem cell transplant responded in the AETHERA study.
buttons
See study results
headline

About classical Hodgkin lymphoma after a stem cell transplant

content
Classical Hodgkin lymphoma, also called Hodgkin’s lymphoma, Hodgkin’s disease, or Hodgkin’s, is a type of cancer of the blood. It starts when lymphocytes, a type of white blood cell, grow out of control.

Sometimes people receive a stem cell transplant if their disease is not well controlled after initial treatment. ADCETRIS may be given after a stem cell transplant to reduce the risk of relapse or worsening disease. This is called consolidation treatment.
heading

What is ADCETRIS?

body
ADCETRIS is a targeted treatment called an antibody-drug conjugate. Learn more about how it works.
cta
Discover how ADCETRIS works
heading

How ADCETRIS is given

body
Learn about what you can expect when starting ADCETRIS treatment for classical Hodgkin lymphoma at high risk of coming back or becoming worse after a stem cell transplant.
cta
Prepare for treatment
heading

Resources and support

body
Find resources, financial assistance information, and ways to connect with others.
cta
Explore ADCETRIS resources
image
Mobile_image
headline

ADCETRIS is a well-established treatment backed by over a decade of clinical data

content
  • Nearly 1700 patients with certain types of lymphoma received treatment with ADCETRIS across 8 clinical trials
  • Over 67,000 patients in the US and over 183,000 patients worldwide have been treated with ADCETRIS since 2011


Healthcare providers have relied on the extensive clinical study data of ADCETRIS when treating their patients. Researchers continue to investigate ADCETRIS in clinical trials today.

headline

Talk to your doctor about ADCETRIS

content
Communicating openly with your doctor is an important part of making sure that your treatment is right for you. Your appointment is an opportunity to share symptoms, ask questions, and discuss your treatment goals. These resources are designed to help you feel confident and prepared to have those conversations with your healthcare provider.
icon
headline

ADCETRIS patient brochure

content

This brochure is intended to help build knowledge and confidence through a detailed overview of ADCETRIS and can help inform treatment discussions with your doctor.

English

Spanish

icon
headline

Doctor Discussion Guide

content

It's important to ask questions and share concerns about ADCETRIS treatment with a doctor. The Doctor Discussion Guide can help you navigate the conversation, so you get the most out of your visit. Take this printable PDF with you to your next appointment.

View the guide

headline

Glossary

content

Relapse: When cancer has returned after signs and symptoms of cancer had reduced or became undetectable.

Stem cell transplant: A procedure in which a patient receives healthy stem cells (blood-forming cells) to replace their own stem cells that have been destroyed by certain cancer treatments.